Exhaled NO levels – A new tool in decision-making about antibiotic treatment

N. Voskresenska, J. Voicehovska, G. Orlikov (Riga, Latvia)

Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Session: Diagnosis and management of respiratory diseases
Session type: Thematic Poster Session
Number: 4160
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Voskresenska, J. Voicehovska, G. Orlikov (Riga, Latvia). Exhaled NO levels – A new tool in decision-making about antibiotic treatment. Eur Respir J 2013; 42: Suppl. 57, 4160

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled nitric oxide and the therapeutic regimens in childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Comparison of exhaled nitric oxide values measured by two offline methods or NO breath
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Exhaled nitric oxide reference values in healthy Tunisian adults
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013

Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Exhaled nitric oxide measurement in the diagnosis and management of pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016


Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO)
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021



The effect of chlorine exposure on Exhaled Nitric Oxide in asthmatic children attending indoor swimming pool
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Exhaled nitric oxide in the assessment of asthma control
Source: Eur Respir J 2007; 30: Suppl. 51, 18s
Year: 2007

Inter-instrument variability in exhaled nitric oxide measurement and implications on test interpretation
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015


Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Exhaled nitric oxide as a biomarker in different COPD phenotypes
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018


Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS)
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Exhaled NO (FENO50) in COPD - Results from the TIE-study
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016